{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T13:04:41Z","timestamp":1789391081974,"version":"build-2803163510"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1097\/mjt.0b013e3182a44055","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T12:17:49Z","timestamp":1380111469000},"page":"e93-e96","source":"Crossref","is-referenced-by-count":18,"title":["Levofloxacin-Induced Hepatotoxicity and Death"],"prefix":"10.1097","volume":"22","author":[{"given":"Muge","family":"Gulen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Oguzhan","family":"Ay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akkan","family":"Avci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayca","family":"Acikalin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferhat","family":"Icme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-17-20210202","first-page":"226","article-title":". Alverine Bagli Toksik Hepatit.","volume":"13","author":"Durakoglu","year":"2002","journal-title":"Turk J Gastroenterol"},{"key":"R3-17-20210202","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1016\/j.clinthera.2010.09.004","article-title":". Acute hepatitis associated with the use of levofloxacin.","volume":"32","author":"Figueira-Coelho","year":"2010","journal-title":"Clin Ther"},{"key":"R4-17-20210202","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1345\/aph.1G111","article-title":". Levofloxacin-induced acute fulminant hepatic failure in a patient with chronic hepatitis B infection.","volume":"39","author":"Coban","year":"2005","journal-title":"Ann Pharmacother"},{"key":"R5-17-20210202","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000057838","article-title":"History of quinolones and their side effects.","volume":"47","author":"Rubinstein","year":"2001","journal-title":"Chemotherapy"},{"key":"R6-17-20210202","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000057843","article-title":"Latest industry information on the safety profile of levofloxacin in Japan.","volume":"47","author":"Yagawa","year":"2001","journal-title":"Chemotherapy"},{"key":"R7-17-20210202","first-page":"113","article-title":"Toksik Hepatit.","volume":"1","author":"Arici","year":"2008","journal-title":"Pamukkale Tip Dergisi"},{"key":"R8-17-20210202","first-page":"1","article-title":". Fulminant viral hepatitis: molecular and cellular basis, and clinical implications.","volume":"2001","author":"Liu","year":"28","journal-title":"Expert Rev Mol Med"},{"key":"R11-17-20210202","first-page":"139","article-title":". Nadir Bir Olgu: Setrizin Kullanimina Bagli Toksik Hepatit.","volume":"10","author":"Yavasoglu","year":"2005","journal-title":"Firat Tip Dergisi"},{"key":"R12-17-20210202","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/hep.20703","article-title":"AASLD position paper: the management of acute liver failure.","volume":"41","author":"Polson","year":"2005","journal-title":"Hepatology"},{"key":"R13-17-20210202","first-page":"447","article-title":". Terbinafine Bagli Toksik Hepatit Olgusu.","volume":"44","author":"Turhan","year":"2002","journal-title":"Gulhane Tip Dergisi"},{"key":"R15-17-20210202","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0140-6736(93)91818-7","article-title":"Acute liver failure: redefining the syndromes.","volume":"342","author":"OGrady","year":"1993","journal-title":"Lancet"},{"key":"R16-17-20210202","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1136\/gut.31.4.365","article-title":"Vasodilatation associated with hepatocellular disease: relation to functional organ failure.","volume":"31","author":"Sherlock","year":"1990","journal-title":"Gut"},{"key":"R17-17-20210202","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8553(21)00362-9","article-title":"Major complications of acute and chronic liver disease.","volume":"17","author":"Munoz","year":"1988","journal-title":"Gastroenterol Clin North Am"}],"container-title":["American Journal of Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MJT.0b013e3182a44055","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T21:42:21Z","timestamp":1646602941000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00045391-201505000-00017"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5]]},"references-count":13,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1097\/mjt.0b013e3182a44055","relation":{},"ISSN":["1075-2765"],"issn-type":[{"value":"1075-2765","type":"print"}],"subject":[],"published":{"date-parts":[[2015,5]]}}}